Register by Friday, February 23 to Save Up to $350!


Uniting Large Pharma, Innovative Biotech & Leading Academics Dedicated to Accelerating Precision Medicine Therapies to Patients in Need

The industry has made unequivocal advances, from tangible progress using artificial intelligence to robust biomarker development, permitting precise prognosis, astute stratification, and meticulous patient monitoring. Unsurprisingly, this is reflected by countless recent approvals, IND filings, and new companies emerging out of stealth-mode.

The Precision Medicine in Inflammatory Bowel Disease Summit is returning for the second year, as the most comprehensive, ultra-specialized meeting uniting experts to explore developments that will fast-track the optimization of drug development and overcome the one-size-fits-all approach to medicine. 

What’s New for 2024?

AI icon

Explore breakthroughs from AI-driven drug repurposing to the AI-enhanced development of wearable technology to monitor IBD disease state at the brand-new AI & Machine Learning dedicated focus day

Speaker Icon

Streamline your pipeline with fresh insights from a brand-new speaker faculty, including thought leaders from Bristol Myers Squibb, Takeda, Merck, Seres Therapeutics, Palatin Technologies, Alumis, and many more.

Data icon

With new speakers comes new data: gain actionable insights on novel strategies, exciting developments and future perspectives to fast-track development in your field!

2024 Expert Speakers Include

Attending Companies Include

40556 - Companies Attending (2)


This meeting presents a great opportunity to connect with others in the Precision Medicine field to share ideas and ways in which to better benefit patients

Past Attendee, Scientific Director, Precision Medicine & Immunology, AbbVie 

This meeting provides a great opportunity to strengthen the case for precision medicine in IBD which will be hugely beneficial for patients.”



Other Events In The Series